Association of Genetic Variants Linked to Late-Onset Alzheimer Disease With Cognitive Test Performance by Midlife.

Association of Genetic Variants Linked to Late-Onset Alzheimer Disease With Cognitive Test Performance by Midlife.
复制标题

DOI:
10.1001/jamanetworkopen.2022.5491
复制
发表时间:
2022-04-01
期刊:
影响因子:
13.8
通讯作者:
Glymour MM
Glymour MM
中科院分区:
医学1区
文献类型:
--
作者:
Zimmerman SC;Brenowitz WD;Calmasini C;Ackley SF;Graff RE;Asiimwe SB;Staffaroni AM;Hoffmann TJ;Glymour MM

文献摘要

参考文献

相似文献

At what age do individuals with higher genetic risk of Alzheimer disease first show cognitive differences from individuals with lower genetic risk, and which of 32 cognitive measures show the earliest difference? In this cross-sectional study of 405 050 individuals, higher genetic risk of Alzheimer disease significantly modified the association of age with 13 of 32 cognitive measures. Best-fitting models suggested that higher genetic risk of Alzheimer disease was associated with changes in cognitive scores of individuals older than 56 years for all 13 measures and older than 47 years for 9 measures. These findings suggest that by early midlife, subtle differences in cognitive measures may emerge among individuals with higher genetic risk of Alzheimer disease. Identifying the youngest age when Alzheimer disease (AD) influences cognition and the earliest affected cognitive domains will improve understanding of the natural history of AD and approaches to early diagnosis. To evaluate the age at which cognitive differences between individuals with higher compared with lower genetic risk of AD are first apparent and which cognitive assessments show the earliest difference. This cross-sectional study used data from UK Biobank participants of European genetic ancestry, aged 40 years or older, who contributed genotypic and cognitive test data from January 1, 2006, to December 31, 2015. Data analysis was performed from March 10, 2020, to January 4, 2022. The AD genetic risk score (GRS), which is a weighted sum of 23 single-nucleotide variations. Seven cognitive tests were administered via touchscreen at in-person visits or online. Cognitive domains assessed included fluid intelligence, episodic memory, processing speed, executive functioning, and prospective memory. Multiple cognitive measures were derived from some tests, yielding 32 separate measures. Interactions between age and AD-GRS for each of the 32 cognitive measures were tested with linear regression using a Bonferroni-corrected P value threshold. For cognitive measures with significant evidence of age by AD-GRS interaction, the youngest age of interaction was assessed with new regression models, with nonlinear specification of age terms. Models with youngest age of interaction from 40 to 70 years, in 1-year increments, were compared, and the best-fitting model for each cognitive measure was chosen. Results across cognitive measures were compared to determine which cognitive indicators showed earliest AD-related change. A total of 405 050 participants (mean [SD] age, 57.1 [7.9] years; 54.1% female) were included. Sample sizes differed across cognitive tests (from 12 455 to 404 682 participants). The AD-GRS significantly modified the association with age on 13 measures derived from the pairs matching (range in difference in mean cognition per decade increase in age for 1-SD higher AD-GRS, 2.5%-11.5%), symbol digit substitution (range in difference in mean cognition per decade increase in age for 1-SD higher AD-GRS, 2.0%-5.8%), and numeric memory tests (difference in mean cognition per decade increase in age for 1-SD higher AD-GRS, 8.8%) (P = 1.56 × 10−3). Best-fitting models suggested that cognitive scores of individuals with a high vs low AD-GRS began to diverge by 56 years of age for all 13 measures and by 47 years of age for 9 measures. In this cross-sectional study, by early midlife, subtle differences in memory and attention were detectable among individuals with higher genetic risk of AD. This cross-sectional study of UK Biobank participants older than 40 years evaluates the youngest age at which the genetic risk scores for Alzheimer disease are associated with cognitive outcomes.
DOI: 10.1093/aje/kwx246
发表时间: 2017-11-01
影响因子: 5
作者:
Fry A;Littlejohns TJ;Sudlow C;Doherty N;Adamska L;Sprosen T;Collins R;Allen NE
通讯作者: Allen NE
DOI: 10.1016/j.neurobiolaging.2018.08.026
发表时间: 2019-01
影响因子: 4.2
作者:
Hodgetts CJ;Shine JP;Williams H;Postans M;Sims R;Williams J;Lawrence AD;Graham KS
通讯作者: Graham KS
DOI: 10.1186/s13742-015-0047-8
发表时间: 2015
期刊: GigaScience
影响因子: 9.2
作者:
Chang CC;Chow CC;Tellier LC;Vattikuti S;Purcell SM;Lee JJ
通讯作者: Lee JJ
对一般认知功能变异的遗传贡献:电荷联盟中全基因组关联研究的荟萃分析(n = 53949)。
DOI: 10.1038/mp.2014.188
发表时间: 2015-02
影响因子: 11
作者:
Davies, G.;Armstrong, N.;Bis, J. C.;Bressler, J.;Chouraki, V.;Giddaluru, S.;Hofer, E.;Ibrahim-Verbaas, C. A.;Kirin, M.;Lahti, J.;van der Lee, S. J.;Le Hellard, S.;Liu, T.;Marioni, R. E.;Oldmeadow, C.;Postmus, I.;Smith, A. V.;Smith, J. A.;Thalamuthu, A.;Thomson, R.;Vitart, V.;Wang, J.;Yu, L.;Zgaga, L.;Zhao, W.;Boxall, R.;Harris, S. E.;Hill, W. D.;Liewald, D. C.;Luciano, M.;Adams, H.;Ames, D.;Amin, N.;Amouyel, P.;Assareh, A. A.;Au, R.;Becker, J. T.;Beiser, A.;Berr, C.;Bertram, L.;Boerwinkle, E.;Buckley, B. M.;Campbell, H.;Corley, J.;De Jager, P. L.;Dufouil, C.;Eriksson, J. G.;Espeseth, T.;Faul, J. D.;Ford, I.;Gottesman, R. F.;Griswold, M. E.;Gudnason, V.;Harris, T. B.;Heiss, G.;Hofman, A.;Holliday, E. G.;Huffman, J.;Kardia, S. L. R.;Kochan, N.;Knopman, D. S.;Kwok, J. B.;Lambert, J-C;Lee, T.;Li, G.;Li, S-C;Loitfelder, M.;Lopez, O. L.;Lundervold, A. J.;Lundqvist, A.;Mather, K. A.;Mirza, S. S.;Nyberg, L.;Oostra, B. A.;Palotie, A.;Papenberg, G.;Pattie, A.;Petrovic, K.;Polasek, O.;Psaty, B. M.;Redmond, P.;Reppermund, S.;Rotter, J. I.;Schmidt, H.;Schuur, M.;Schofield, P. W.;Scott, R. J.;Steen, V. M.;Stott, D. J.;Van Swieten, J. C.;Taylor, K. D.;Trollor, J.;Trompet, S.;Uitterlinden, A. G.;Weinstein, G.;Widen, E.;Windham, B. G.;Jukema, J. W.;Wright, A. F.;Wright, M. J.;Yang, Q.;Amieva, H.;Attia, J. R.;Bennett, D. A.;Brodaty, H.;de Craen, A. J. M.;Hayward, C.;Ikram, M. A.;Lindenberger, U.;Nilsson, L-G;Porteous, D. J.;Raikkonen, K.;Reinvang, I.;Rudan, I.;Sachdev, P. S.;Schmidt, R.;Schofield, P. R.;Srikanth, V.;Starr, J. M.;Turner, S. T.;Weir, D. R.;Wilson, J. F.;Van Duijn, C.;Launer, L.;Fitzpatrick, A. L.;Seshadri, S.;Mosley, T. H., Jr.;Deary, I. J.
通讯作者: Deary, I. J.
DOI: 10.1212/wnl.0000000000005415
发表时间: 2018-05-01
期刊: NEUROLOGY
影响因子: 9.9
作者:
Ge, Tian;Sabuncu, Mert R.;Mormino, Elizabeth C.
通讯作者: Mormino, Elizabeth C.